UB Paderborn / Katalog / Suche / in CDI

Primary Sjögren's Syndrome: Diagnostic and Prognostic Value of Salivary Gland Ultrasonography Using a Simplified Scoring System

Arthritis care & research (2010), 2014-07, Vol.66 (7), p.1102-1107

2014

Link zum Volltext

Verfügbarkeit prüfen

EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome

Annals of the rheumatic diseases, 2010-06, Vol.69 (6), p.1103-1109

2010

Link zum Volltext

Verfügbarkeit prüfen

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

Rheumatology (Oxford, England), 2015-12, Vol.54 (12), p.2230-2238

2015

Link zum Volltext

Verfügbarkeit prüfen

Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker

Arthritis research & therapy, 2017-02, Vol.19 (1), p.20-20, Article 20

2017

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis

PloS one, 2016-07, Vol.11 (7), p.e0159384-e0159384

2016

Link zum Volltext

Verfügbarkeit prüfen

Combined genetic deficiencies of the classical complement pathway are strongly associated with both systemic lupus erythematosus and primary Sjögren's syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2022-06, Vol.74 (11), p.1842

2022

Link zum Volltext

Verfügbarkeit prüfen

EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.968-972

2011

Link zum Volltext

Verfügbarkeit prüfen

Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study

PloS one, 2014-05, Vol.9 (5), p.e98024-e98024

2014

Link zum Volltext

Verfügbarkeit prüfen

Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study

Arthritis research & therapy, 2023-06, Vol.25 (1), p.100-100, Article 100

2023

Link zum Volltext

Verfügbarkeit prüfen

Classification criteria for Sjögren's syndrome: we actually need to definitively resolve the long debate on the issue

Annals of the rheumatic diseases, 2013-04, Vol.72 (4), p.476-478

2013

Link zum Volltext

Verfügbarkeit prüfen

Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study

Arthritis research & therapy, 2023-06, Vol.25 (1), p.109-109, Article 109

2023

Link zum Volltext

Verfügbarkeit prüfen

Outcome measures for primary Sjögren's syndrome: A comprehensive review

Journal of autoimmunity, 2014-06, Vol.51 (Jan 7), p.51-56

2014

Link zum Volltext

Verfügbarkeit prüfen

Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients

Arthritis research & therapy, 2018-07, Vol.20 (1), p.150-150, Article 150

2018

Link zum Volltext

Verfügbarkeit prüfen

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations

Expert review of clinical immunology, 2016-02, Vol.12 (2), p.137-156

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology

Scandinavian journal of clinical and laboratory investigation, 2019-02, Vol.79 (1-2), p.7-16

2019

Link zum Volltext

Verfügbarkeit prüfen

Salivary gland ultrasound abnormalities in primary Sjögren’s syndrome: consensual US-SG core items definition and reliability

Rheumatic & musculoskeletal diseases open, 2017-06, Vol.3 (1), p.e000364-e000364

2017

Link zum Volltext

Verfügbarkeit prüfen

Relationship of Sjögren's Syndrome to Other Connective Tissue and Autoimmune Disorders

Rheumatic diseases clinics of North America, 2008-11, Vol.34 (4), p.935-947

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA

Rheumatic & musculoskeletal diseases open, 2023-03, Vol.9 (1), p.e002934

2023

Link zum Volltext

Verfügbarkeit prüfen

PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis

Rheumatology and therapy., 2023-04, Vol.10 (2), p.489-505

2023

Link zum Volltext

Verfügbarkeit prüfen

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

Rheumatology (Oxford, England), 2017-07, Vol.56 (7), p.1245-1245

2017

Link zum Volltext

Verfügbarkeit prüfen

The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis

Journal of rheumatology, 2008-04, Vol.35 (4), p.668

2008

Link zum Volltext

Verfügbarkeit prüfen

Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome

La Presse médicale (1983), 2012-09, Vol.41 (9), p.e511-e516

2012

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling

Arthritis & rheumatology (Hoboken, N.J.), 2015-09, Vol.67 (9), p.2427-2436

2015

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies present before symptom onset in primary Sjögren syndrome

JAMA : the journal of the American Medical Association, 2013-11, Vol.310 (17), p.1854

2013

Link zum Volltext

Verfügbarkeit prüfen

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

Annals of the rheumatic diseases, 2011-08, Vol.70 (8), p.1363-1368

2011

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Primary Sjögren's Syndrome: Diagnostic and Prognostic Value of Salivary Gland Ultrasonography Using a Simplified Scoring System

EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis

Combined genetic deficiencies of the classical complement pathway are strongly associated with both systemic lupus erythematosus and primary Sjögren's syndrome

EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome

Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study

Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study

Classification criteria for Sjögren's syndrome: we actually need to definitively resolve the long debate on the issue

Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study

Outcome measures for primary Sjögren's syndrome: A comprehensive review

Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations

Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology

Salivary gland ultrasound abnormalities in primary Sjögren’s syndrome: consensual US-SG core items definition and reliability

Relationship of Sjögren's Syndrome to Other Connective Tissue and Autoimmune Disorders

Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA

PsABIOnd Study and eDaily Substudy Design: Long-Term Effectiveness and Safety of Guselkumab and IL-17 Inhibitors in Routine Clinical Practice in Patients with Psoriatic Arthritis

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis

Predictors for the development of non-Hodgkin lymphoma in primary Sjögren's syndrome

Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling

Autoantibodies present before symptom onset in primary Sjögren syndrome

Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome

Suchergebnisse filtern